These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23209150)

  • 1. Oncogenes in cell survival and cell death.
    Shortt J; Johnstone RW
    Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23209150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perillyl alcohol induces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells.
    Clark SS
    Oncology; 2006; 70(1):13-8. PubMed ID: 16439861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer.
    Khan Z; Bisen PS
    Biochim Biophys Acta; 2013 Aug; 1836(1):123-45. PubMed ID: 23602834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma.
    Liu Y; Azizian NG; Dou Y; Pham LV; Li Y
    J Hematol Oncol; 2019 Nov; 12(1):119. PubMed ID: 31752970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation.
    Monteghirfo S; Tosetti F; Ambrosini C; Stigliani S; Pozzi S; Frassoni F; Fassina G; Soverini S; Albini A; Ferrari N
    Mol Cancer Ther; 2008 Sep; 7(9):2692-702. PubMed ID: 18790751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traps to catch unwary oncogenes.
    Hueber AO; Evan GI
    Trends Genet; 1998 Sep; 14(9):364-7. PubMed ID: 9769732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative MYC blocks transformation by ABL oncogenes.
    Sawyers CL; Callahan W; Witte ON
    Cell; 1992 Sep; 70(6):901-10. PubMed ID: 1525828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
    Sipos F; Firneisz G; Műzes G
    World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species.
    Joseph P; Muchnok TK; Klishis ML; Roberts JR; Antonini JM; Whong WZ; Ong T
    Toxicol Sci; 2001 Jun; 61(2):295-303. PubMed ID: 11353138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers.
    Sun K; Atoyan R; Borek MA; Dellarocca S; Samson ME; Ma AW; Xu GX; Patterson T; Tuck DP; Viner JL; Fattaey A; Wang J
    Mol Cancer Ther; 2017 Feb; 16(2):285-299. PubMed ID: 27980108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MYC-WDR5 Nexus and Cancer.
    Thomas LR; Foshage AM; Weissmiller AM; Tansey WP
    Cancer Res; 2015 Oct; 75(19):4012-5. PubMed ID: 26383167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
    Cortez D; Kadlec L; Pendergast AM
    Mol Cell Biol; 1995 Oct; 15(10):5531-41. PubMed ID: 7565705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The v-myc oncogene.
    Lee CM; Reddy EP
    Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis.
    Dengler MA; Staiger AM; Gutekunst M; Hofmann U; Doszczak M; Scheurich P; Schwab M; Aulitzky WE; van der Kuip H
    PLoS One; 2011; 6(9):e25139. PubMed ID: 21949869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.
    Selvakumaran M; Lin HK; Sjin RT; Reed JC; Liebermann DA; Hoffman B
    Mol Cell Biol; 1994 Apr; 14(4):2352-60. PubMed ID: 8139540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation.
    Fang Z; Jung KH; Yan HH; Kim SJ; Son MK; Rumman M; Lee H; Kim KW; Yoo HD; Hong SS
    Int J Oncol; 2015 Jul; 47(1):253-61. PubMed ID: 25963192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy.
    Fang ZH; Dong CL; Chen Z; Zhou B; Liu N; Lan HF; Liang L; Liao WB; Zhang L; Han ZC
    J Cell Mol Med; 2009 Aug; 13(8B):2039-2052. PubMed ID: 19602047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study).
    Zhelev Z; Bakalova R; Ohba H; Ewis A; Ishikawa M; Shinohara Y; Baba Y
    FEBS Lett; 2004 Jul; 570(1-3):195-204. PubMed ID: 15251464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene regulation of endonuclease activation in apoptosis.
    McConkey DJ; Fernandez A; Trent J; Ananthaswamy HN
    Cancer Lett; 1995 Jul; 94(1):9-16. PubMed ID: 7621450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.